Margaret Grieco - Gender and health – March Gender and health: a social movements’ agenda for Big Pharma Margaret Grieco, Professor of Transport and Society, Napier University and Salaried Visiting Full Professor, Cornell University

Margaret Grieco - Gender and health – March Introduction: health, gender and the globalizing of knowledge n Not one of the chief scientists or heads of research at any of the major pharmaceutical companies is a woman. Why that's the case is much less clear. n International People’s Health University, Nicaragua n one of its courses On-line activist health personnel linked to universities provide one form of new social action in health, n global social movements around meeting the challenge of AIDS/HIV provide another

Margaret Grieco - Gender and health – March Social justice issues have been firmly placed on the Big Pharma agenda n In this context, Big Pharma has come under challenge n The regulation of food supplements undermines the unregulated traditional health space of ‘wise women’ des_food_supplements_directive_may_go_ahead.htmhttp:// des_food_supplements_directive_may_go_ahead.htm n Social movements around gender and health are now a feature of the modern political scene

Margaret Grieco - Gender and health – March HIV/AIDS: from pricing out survival to ensuring gender equity in provision. n HIV/AIDS drugs remain highly cost prohibitive pharmaceutical companies refuse to grant licenses to allow generic drugs to be produced, which would significantly reduce prices and increase access to lifesaving medications. n Major Big Pharma player as US Global AIDS Coordinator n HIV/AIDS as women’s disease within Africa for example, there are particular features of the female body which make women more vulnerable to the disease n Center For Gender and Health Equity submission to US Global AIDS coordinator on the web see Gender, AIDS, and ARV Therapies: Ensuring that Women Gain Equitable Access to Drugs within U.S. Funded Treatment Initiatives microbicides as a technology which would particularly benefit women in the context of HIV/AIDS also advocated by the International Community of Women Living with AIDS

Margaret Grieco - Gender and health – March n The social movement pressure to lower the prices of critical drugs and to extend coverage of HIV/AIDS treatment by the direct lobbying Big Pharma n Influence of lobbying via governments and international institutions. the pressure to discard unjust international arrangements in the context of regional health crises grows the protection of patents at the cost of public health, including women’s health, becomes increasingly unacceptable

Margaret Grieco - Gender and health – March A directable market?: the medicalisation of ‘women’s problems’ n H. Hartley "Big Pharma" in our bedrooms: an analysis of the medicalization of women's sexual problems ion#descriptionhttp:// ion#description n The growing health burden caused by the continued massive selling of sickness -- and of harmful drugs. n Hot flush for Big Pharma n History of Depo Provera n Blockbuster medicalisation of women’s biology

Margaret Grieco - Gender and health – March Engulfing the alternative: the battle of the supplements n Folk practices harnessed as product under patent n Breaking the Pattern – the San people and hoodia n Food supplements under international regulation Revised.pdf Revised.pdf

Margaret Grieco - Gender and health – March Conclusion: purchasing authority n Tension and contradictions in the academy n Further links on this topic: documentation-of.htmlhttp://hcrenewal.blogspot.com/2005/12/more-summary-and-much- documentation-of.html n “A pharmaceutical giant has promised to give a full guarantee of independence to academic researchers whose work it funds in a move that follows widespread concern over the company's handling of a major UK drugs study”.